Fritextsökning
Innehållstyper
-
Hoppas på Kina
Förändringarna i Kinas enbarnspolitik kan ha en positiv påverkan på försäljningen av fertilitetsprodukter tror Vitrolife, som har ökat sitt resultat genom förvärv.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Framåt för Sobi
Ökar intäkterna och inväntar godkännande av hemofililäkemedlet Elocta.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Här odlar forskarna minihjärnor
Genom att odla hjärnsubstans vill österrikiska forskare revolutionera forskningen inom neurosjukdomar, läkemedelsutveckling och samtidigt ersätta djurförsök.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Karin Meyer lämnar PCG
Karin Meyer går till nytt jobb.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Startskott för blödarstudie
Nu doseras första patienten i fas II/III-studien med Sobis och Biogenidecs läkemedelskandidat mot blödarsjuka.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Presenterar data från två kliniska studier
Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Biovitrum får orphan drug-status i EU
Färre behandlingstillfällen för blödarsjuka är i sikte med Swedish Orphan Biovitrums läkemedelskandidat. Nu kan läkemedlet nå den europeiska marknaden fortare.
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
Swetox får 30 miljoner
Ska forska på hormonstörande ämnen.